Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Biochemical Pharmacology
|
November 14, 1997
Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways
J M Lenhard, S A Kliewer, M A Paulik, et al.
The Biochemical Journal
|
June 15, 1996
Phosphorylation of a cAMP-specific phosphodiesterase (HSPDE4B2B) by mitogen-activated protein kinase
J M Lenhard, D B Kassel, W J Rocque, et al.
Pharmaceutical Research
|
July 1, 1998
Development of infrared imaging to measure thermogenesis in cell culture: thermogenic effects of uncoupling protein-2, troglitazone, and beta-adrenoceptor agonists
M A Paulik, R G Buckholz, M E Lancaster, et al.
Diabetes
|
March 1, 1997
Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition
W T Garvey, L Maianu, A Kennedy, et al.
Antiviral Research
|
September 21, 2000
HIV protease inhibitors block adipogenesis and increase lipolysis in vitro
J M Lenhard, E S Furfine, R G Jain, et al.
Journal of Cellular Biochemistry
|
June 15, 1997
Identification of Rad's effector-binding domain, intracellular localization, and analysis of expression in Pima Indians
M A Paulik, L L Hamacher, D P Yarnall, et al.
Diabetologia
|
May 20, 1999
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction
J M Lenhard, M E Lancaster, M A Paulik, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 29, 1997
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
S A Kliewer, S S Sundseth, S A Jones, et al.
Journal of Medicinal Chemistry
|
December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent
J E Cobb, S G Blanchard, E G Boswell, et al.
Journal of Medicinal Chemistry
|
December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety
J L Collins, S G Blanchard, G E Boswell, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Biochemical Pharmacology
|
November 14, 1997
Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways
J M Lenhard, S A Kliewer, M A Paulik, et al.
The Biochemical Journal
|
June 15, 1996
Phosphorylation of a cAMP-specific phosphodiesterase (HSPDE4B2B) by mitogen-activated protein kinase
J M Lenhard, D B Kassel, W J Rocque, et al.
Pharmaceutical Research
|
July 1, 1998
Development of infrared imaging to measure thermogenesis in cell culture: thermogenic effects of uncoupling protein-2, troglitazone, and beta-adrenoceptor agonists
M A Paulik, R G Buckholz, M E Lancaster, et al.
Diabetes
|
March 1, 1997
Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition
W T Garvey, L Maianu, A Kennedy, et al.
Antiviral Research
|
September 21, 2000
HIV protease inhibitors block adipogenesis and increase lipolysis in vitro
J M Lenhard, E S Furfine, R G Jain, et al.
Journal of Cellular Biochemistry
|
June 15, 1997
Identification of Rad's effector-binding domain, intracellular localization, and analysis of expression in Pima Indians
M A Paulik, L L Hamacher, D P Yarnall, et al.
Diabetologia
|
May 20, 1999
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction
J M Lenhard, M E Lancaster, M A Paulik, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 29, 1997
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
S A Kliewer, S S Sundseth, S A Jones, et al.
Journal of Medicinal Chemistry
|
December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent
J E Cobb, S G Blanchard, E G Boswell, et al.
Journal of Medicinal Chemistry
|
December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety
J L Collins, S G Blanchard, G E Boswell, et al.
Page
of 4